BioSpace News Archive

Asensus Surgical, Inc. announced that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at three upcoming virtual investor conferences.

Merck, known as MSD outside the United States and Canada, announced that data spanning 20 types of cancer from its leading oncology research program will be presented at the European Society for Medical Oncology Congress 2021 from Sept. 16–21.

Recro Pharma, Inc. and BioCorRx, Inc. announced the expansion of the companies’ ongoing relationship with the signing of a new development and manufacturing agreement.

Calithera Biosciences, Inc., a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, announced that it will present a trial in progress poster of the Phase 2 study of telaglenastat at the International Association for the Study of Lung Cancer 2021 World Conference on Lung Cancer.

Healthcare organizations around the world have started acquiring services from global healthcare outsourcing market as availing these services can help these organizations control the increasing costs of providing backend and management healthcare services.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to a recent study by Fact.MR, the global terminal sterilization market is estimated to exhibit positive growth in the forecast period 2021 to 2031.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs.

GNT Pharma Inc. reported that the Korea Ministry of Food and Drug Safety has approved the Investigational New Drug Application for a phase III study of nelonemdaz for acute ischemic stroke patients.

Underdog Pharmaceuticals, a key investment of Michael Greve’s rejuvenation biotech VC Kizoo is one of the first companies to be awarded the Innovation Passport under the United Kingdom’s Innovative Licensing and Access Pathway.